135 related articles for article (PubMed ID: 36537311)
1. Sotrovimab therapy in solid organ transplant recipients with mild to moderate COVID-19: a systematic review and meta-analysis.
Farhadian N; Farhadian M; Zamanian MH; Taghadosi M; Vaziri S
Immunopharmacol Immunotoxicol; 2023 Dec; 45(4):402-408. PubMed ID: 36537311
[No Abstract] [Full Text] [Related]
2. Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild-to-moderate coronavirus disease 2019 during the Omicron epoch.
Yetmar ZA; Beam E; O'Horo JC; Seville MT; Brumble L; Ganesh R; Razonable RR
Transpl Infect Dis; 2022 Aug; 24(4):e13901. PubMed ID: 35848574
[TBL] [Abstract][Full Text] [Related]
3. Real-world experience with available, outpatient COVID-19 therapies in solid organ transplant recipients during the omicron surge.
Radcliffe C; Palacios CF; Azar MM; Cohen E; Malinis M
Am J Transplant; 2022 Oct; 22(10):2458-2463. PubMed ID: 35583664
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era.
Hedvat J; Lange NW; Salerno DM; DeFilippis EM; Kovac D; Corbo H; Chen JK; Choe JY; Lee JH; Anamisis A; Jennings DL; Codispodo G; Shertel T; Brown RS; Pereira MR
Am J Transplant; 2022 Nov; 22(11):2682-2688. PubMed ID: 35801839
[TBL] [Abstract][Full Text] [Related]
5. Sotrovimab in solid organ transplant recipients with COVID-19: a systematic review and meta-analysis.
Amani B; Shabestan R; Rajabkhah K; Amani B
Korean J Transplant; 2023 Dec; 37(4):277-285. PubMed ID: 37916433
[TBL] [Abstract][Full Text] [Related]
6. Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Gupta A; Gonzalez-Rojas Y; Juarez E; Crespo Casal M; Moya J; Rodrigues Falci D; Sarkis E; Solis J; Zheng H; Scott N; Cathcart AL; Parra S; Sager JE; Austin D; Peppercorn A; Alexander E; Yeh WW; Brinson C; Aldinger M; Shapiro AE;
JAMA; 2022 Apr; 327(13):1236-1246. PubMed ID: 35285853
[TBL] [Abstract][Full Text] [Related]
7. Antispike monoclonal antibodies for prevention and treatment of coronavirus disease-2019 in solid organ transplant recipients.
Yetmar ZA; Bhaimia E; Razonable RR
Curr Opin Organ Transplant; 2022 Aug; 27(4):269-276. PubMed ID: 36354253
[TBL] [Abstract][Full Text] [Related]
8. A single-center review of pre-exposure prophylaxis with tixagevimab-cilgavimab in solid organ transplant recipients.
Morado F; Davoudi R; Kawewat-Ho P; Nanda N; Cartus R; Shaikh SA
Transpl Infect Dis; 2023 Aug; 25(4):e14086. PubMed ID: 37314092
[TBL] [Abstract][Full Text] [Related]
9. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
Yetmar ZA; Bhaimia E; Bierle DM; Ganesh R; Razonable RR
Transpl Infect Dis; 2022 Apr; 24(2):e13779. PubMed ID: 34932874
[TBL] [Abstract][Full Text] [Related]
10. Incidence, Risk Factors, and Outcomes of COVID-19 Infection in a Large Cohort of Solid Organ Transplant Recipients.
Sahota A; Tien A; Yao J; Dong E; Herald J; Javaherifar S; Neyer J; Hwang J; Lee R; Fong TL
Transplantation; 2022 Dec; 106(12):2426-2434. PubMed ID: 36436102
[TBL] [Abstract][Full Text] [Related]
11. Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience.
Pinchera B; Buonomo AR; Scotto R; Carrano R; Salemi F; Galluccio F; Guarino M; Viceconte G; Schiano Moriello N; Giaccone A; Gallicchio A; Zappulo E; Villari R; Gentile I;
Transplantation; 2022 Jul; 106(7):e343-e345. PubMed ID: 35349534
[No Abstract] [Full Text] [Related]
12. Impact of Vaccination and Early Monoclonal Antibody Therapy on Coronavirus Disease 2019 Outcomes in Organ Transplant Recipients During the Omicron Wave.
Solera JT; Árbol BG; Alshahrani A; Bahinskaya I; Marks N; Humar A; Kumar D
Clin Infect Dis; 2022 Dec; 75(12):2193-2200. PubMed ID: 35445690
[TBL] [Abstract][Full Text] [Related]
13. Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C).
Bell CF; Bobbili P; Desai R; Gibbons DC; Drysdale M; DerSarkissian M; Patel V; Birch HJ; Lloyd EJ; Zhang A; Duh MS;
Clin Drug Investig; 2024 Mar; 44(3):183-198. PubMed ID: 38379107
[TBL] [Abstract][Full Text] [Related]
14. Effect of immunosuppression maintenance in solid organ transplant recipients with COVID-19: Systematic review and meta-analysis.
Karruli A; Spiezia S; Boccia F; Gagliardi M; Patauner F; Salemme A; Maiello C; Zampino R; Durante-Mangoni E
Transpl Infect Dis; 2021 Aug; 23(4):e13595. PubMed ID: 33641202
[TBL] [Abstract][Full Text] [Related]
15. Assessment of symptoms in COMET-ICE, a phase 2/3 study of sotrovimab for early treatment of non-hospitalized patients with COVID-19.
Satram S; Ghafoori P; Reyes CM; Keeley TJH; Birch HJ; Brintziki D; Aldinger M; Alexander E; Lopuski A; Sarkis EH; Gupta A; Shapiro AE; Powers JH
J Patient Rep Outcomes; 2023 Sep; 7(1):92. PubMed ID: 37702920
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: A comparative analysis from a multicenter study.
Heldman MR; Kates OS; Safa K; Kotton CN; Georgia SJ; Steinbrink JM; Alexander BD; Hemmersbach-Miller M; Blumberg EA; Crespo MM; Multani A; Lewis AV; Eugene Beaird O; Haydel B; La Hoz RM; Moni L; Condor Y; Flores S; Munoz CG; Guitierrez J; Diaz EI; Diaz D; Vianna R; Guerra G; Loebe M; Rakita RM; Malinis M; Azar MM; Hemmige V; McCort ME; Chaudhry ZS; Singh P; Hughes K; Velioglu A; Yabu JM; Morillis JA; Mehta SA; Tanna SD; Ison MG; Tomic R; Candace Derenge A; van Duin D; Maximin A; Gilbert C; Goldman JD; Sehgal S; Weisshaar D; Girgis RE; Nelson J; Lease ED; Limaye AP; Fisher CE;
Am J Transplant; 2021 Aug; 21(8):2774-2784. PubMed ID: 34008917
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes of Sotrovimab Treatment in 10 High-Risk Patients with Mild COVID-19: A Case Series.
Takeda K; Kasai H; Sakao S; Saito M; Shikano K; Naito A; Abe M; Kawasaki T; Yahaba M; Taniguchi T; Igari H; Suzuki T
Am J Case Rep; 2022 Jul; 23():e936832. PubMed ID: 35802524
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of COVID-19 in solid organ transplant recipients following COVID-19 vaccination: A multicenter case series.
Saharia KK; Anjan S; Streit J; Beekmann SE; Polgreen PM; Kuehnert M; Segev DL; Baddley JW; Miller RA;
Transpl Infect Dis; 2022 Apr; 24(2):e13774. PubMed ID: 34905269
[TBL] [Abstract][Full Text] [Related]
19. Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave.
Solera JT; Árbol BG; Bahinskaya I; Marks N; Humar A; Kumar D
Am J Transplant; 2023 Jan; 23(1):78-83. PubMed ID: 36148607
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 in hospitalized solid organ transplant recipients in a nationwide registry study.
Moreno-Torres V; Martínez-Urbistondo M; Calderón-Parra J; Mills P; Muñoz-Serrano A; Arias-Milla A; Benítez L; Aguilar-Pérez M; Múñez-Rubio E; Ramos-Martínez A; Fernández-Cruz A; Cuervas-Mons V; de Mendoza C
Int J Infect Dis; 2023 Sep; 134():154-159. PubMed ID: 37321473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
